Package 50242-214-03

{"route": ["SUBCUTANEOUS"], "spl_id": "e633fdb6-7fbc-4072-93ed-4e30abc6c3a1", "openfda": {"nui": ["N0000175794", "N0000175793", "N0000175792"], "unii": ["2P471X1Z11"], "rxcui": ["1657209", "1657212", "2058943", "2058946", "2058949", "2058950", "2663917", "2663918", "2663920", "2663923", "2673760", "2673761", "2673762", "2673763"], "spl_set_id": ["7f6a2191-adfb-48b9-9bfa-0d9920479f0d"], "pharm_class_pe": ["Decreased IgE Activity [PE]"], "pharm_class_epc": ["Anti-IgE [EPC]"], "pharm_class_moa": ["IgE-directed Antibody Interactions [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (50242-214-01)  / .5 mL in 1 SYRINGE, GLASS", "package_ndc": "50242-214-01", "marketing_start_date": "20180928"}, {"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (50242-214-03)  / .5 mL in 1 SYRINGE, GLASS", "package_ndc": "50242-214-03", "marketing_start_date": "20230818"}, {"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (50242-214-55)  / .5 mL in 1 SYRINGE, GLASS", "package_ndc": "50242-214-55", "marketing_start_date": "20230818"}, {"sample": true, "description": "1 SYRINGE, GLASS in 1 CARTON (50242-214-83)  / .5 mL in 1 SYRINGE, GLASS", "package_ndc": "50242-214-83", "marketing_start_date": "20230818"}, {"sample": true, "description": "1 SYRINGE, GLASS in 1 CARTON (50242-214-86)  / .5 mL in 1 SYRINGE, GLASS", "package_ndc": "50242-214-86", "marketing_start_date": "20180928"}, {"sample": true, "description": "1 SYRINGE, GLASS in 1 CARTON (50242-214-99)  / .5 mL in 1 SYRINGE, GLASS", "package_ndc": "50242-214-99", "marketing_start_date": "20230818"}], "brand_name": "Xolair PFS", "product_id": "50242-214_e633fdb6-7fbc-4072-93ed-4e30abc6c3a1", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anti-IgE [EPC]", "Decreased IgE Activity [PE]", "IgE-directed Antibody Interactions [MoA]"], "product_ndc": "50242-214", "generic_name": "omalizumab", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Xolair PFS", "active_ingredients": [{"name": "OMALIZUMAB", "strength": "75 mg/.5mL"}], "application_number": "BLA103976", "marketing_category": "BLA", "marketing_start_date": "20180928", "listing_expiration_date": "20261231"}